Invasive Aspergillosis Complicating Severe COVID-19: Cumulative Incidence, Risk Factors, and Outcomes Between the First Wave of the Pandemic and Subsequent Waves, According to the ECMM/ISHAM Classification and a Local Case Assessment
Abstract
The role of severe COVID-19 as an independent risk factor for invasive aspergillosis remains debated, with reported incidences varying widely across studies. We compared the cumulative incidence, risk factors, and outcomes of invasive pulmonary mold infection (IPMI) in intensive care unit patients with confirmed COVID-19 during the first epidemic wave and subsequent waves up to March 2021 at La Pitié-Salpêtrière Hospital, Paris, France. Patients were systematically screened for fungal infections and classified according to ECMM/ISHAM criteria and a more stringent local assessment. The study included 259 patients (n = 171, first wave and n = 88, subsequent waves). Patient characteristics were similar between periods, although short-course corticosteroid therapy increased over time. Mortality rates remained unchanged. Cumulative incidence of IPMI did not differ significantly between waves, regardless of the classification system used: 12.1% versus 15.1% with ECMM/ISHAM criteria and 4.2% versus 5.8% with local assessment. IPMI was associated with solid organ transplantation and pre-existing long-term corticosteroid therapy, whereas short-course corticosteroid therapy for COVID-19 was not associated with increased risk. IPMI was strongly associated with 90-day mortality. Classification as probable COVID-19-Associated Pulmonary Aspergillosis using the ECMM/ISHAM criteria may be partly influenced by the number of diagnostic samples collected. Overall, our findings underline that the classification system substantially influences both incidence estimates and the interpretation of survival outcomes.
Related
- Multidimensional institutional learning curve of ultrasound-guided percutaneous transthoracic lung biopsy: a cumulative sum analysis with case-mix assessment
- Cumulative Sonographic Features From the Morphological Uterus Sonographic Assessment (MUSA) System and Clinical Severity of Adenomyosis in Congolese Women: A Multicenter Study in Kinshasa, Democratic Republic of the Congo
- Predicting subsequent-year physical fitness assessment failure in university students using longitudinal data and explainable machine learning
- Development and validation of a cumulative risk model and assessment tool for radiation-induced hypothyroidism in head and neck cancer: a multicentre study
- Symptom severity at first digital self-assessment is not associated with greater subsequent booking of professional care on a Saudi mental health platform: a cohort study of 5,524 users
BibTeX
@article{blaize2026invasive,
title = {{Invasive Aspergillosis Complicating Severe COVID-19: Cumulative Incidence, Risk Factors, and Outcomes Between the First Wave of the Pandemic and Subsequent Waves, According to the ECMM/ISHAM Classification and a Local Case Assessment}},
author = {Marion Blaize and Charles Gibert and Dimitri Kornblum and Sophie Demeret and Jean-Michel Constantin and Antoine Monsel and Julien Mayaux and Charles-Edouard Luyt and Alexandre Lampros and Laure Kamus and Arnaud Fekkar},
journal = {Journal of Fungi},
year = {2026},
month = sep,
doi = {10.3390/jof12090652},
url = {https://hal.science/hal-05739405v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Invasive Aspergillosis Complicating Severe COVID-19: Cumulative Incidence, Risk Factors, and Outcomes Between the First Wave of the Pandemic and Subsequent Waves, According to the ECMM/ISHAM Classification and a Local Case Assessment
AU - Marion Blaize
AU - Charles Gibert
AU - Dimitri Kornblum
AU - Sophie Demeret
AU - Jean-Michel Constantin
AU - Antoine Monsel
AU - Julien Mayaux
AU - Charles-Edouard Luyt
AU - Alexandre Lampros
AU - Laure Kamus
AU - Arnaud Fekkar
PY - 2026
DA - 2026/09/01
JO - Journal of Fungi
DO - 10.3390/jof12090652
UR - https://hal.science/hal-05739405v1
AB - The role of severe COVID-19 as an independent risk factor for invasive aspergillosis remains debated, with reported incidences varying widely across studies. We compared the cumulative incidence, risk factors, and outcomes of invasive pulmonary mold infection (IPMI) in intensive care unit patients with confirmed COVID-19 during the first epidemic wave and subsequent waves up to March 2021 at La Pitié-Salpêtrière Hospital, Paris, France. Patients were systematically screened for fungal infections and classified according to ECMM/ISHAM criteria and a more stringent local assessment. The study included 259 patients (n = 171, first wave and n = 88, subsequent waves). Patient characteristics were similar between periods, although short-course corticosteroid therapy increased over time. Mortality rates remained unchanged. Cumulative incidence of IPMI did not differ significantly between waves, regardless of the classification system used: 12.1% versus 15.1% with ECMM/ISHAM criteria and 4.2% versus 5.8% with local assessment. IPMI was associated with solid organ transplantation and pre-existing long-term corticosteroid therapy, whereas short-course corticosteroid therapy for COVID-19 was not associated with increased risk. IPMI was strongly associated with 90-day mortality. Classification as probable COVID-19-Associated Pulmonary Aspergillosis using the ECMM/ISHAM criteria may be partly influenced by the number of diagnostic samples collected. Overall, our findings underline that the classification system substantially influences both incidence estimates and the interpretation of survival outcomes.
SN - 2309-608X
ER -